106 related articles for article (PubMed ID: 6163695)
1. Electrophoretic mobility test (EMT): studies on lymphocyte response and mechanism of the test using a rat tumor model.
Harthus HP; Ax W
Immunobiology; 1981; 158(3):151-72. PubMed ID: 6163695
[TBL] [Abstract][Full Text] [Related]
2. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Hoffmann W; Werner W; Steiner R; Kaufmann R
Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests.
Shenton BK; Jenssen HL; Werner H; Field EJ
J Immunol Methods; 1977; 14(2):123-39. PubMed ID: 138709
[TBL] [Abstract][Full Text] [Related]
4. Target cell - substratum interaction. I. Effect of primed lymphocytes on a rat mammary adenocarcinoma tumor cell line.
David GS; Wiglesworgh CM
Immunol Commun; 1978; 7(3):337-52. PubMed ID: 77840
[TBL] [Abstract][Full Text] [Related]
5. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
[No Abstract] [Full Text] [Related]
6. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
[TBL] [Abstract][Full Text] [Related]
7. Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat.
Quan N; Zhang Z; Demetrikopoulos MK; Kitson RP; Chambers WH; Goldfarb RH; Weiss JM
Cancer Res; 1999 Mar; 59(5):1080-9. PubMed ID: 10070966
[TBL] [Abstract][Full Text] [Related]
8. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
Oncology; 1978; 35(4):163-7. PubMed ID: 81476
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
[TBL] [Abstract][Full Text] [Related]
10. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
[TBL] [Abstract][Full Text] [Related]
11. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity.
Archer TP; Bretscher P; Ziola B
Clin Exp Metastasis; 1990; 8(6):519-32. PubMed ID: 2225567
[TBL] [Abstract][Full Text] [Related]
13. An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response.
Lando PA; Edgington TS
J Immunol; 1985 Nov; 135(5):3587-95. PubMed ID: 4045197
[TBL] [Abstract][Full Text] [Related]
14. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
Christensen ND; Kreider JW; Horetsky RL
Cancer Res; 1988 Feb; 48(4):943-9. PubMed ID: 2962735
[TBL] [Abstract][Full Text] [Related]
15. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
Huber SA; Bigi G; Lucas ZJ
Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
[TBL] [Abstract][Full Text] [Related]
17. Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.
Christensen ND; Kreider JW; Bartlett GL; Horetsky RL
Cell Immunol; 1986 Feb; 97(2):433-45. PubMed ID: 3091274
[TBL] [Abstract][Full Text] [Related]
18. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL
J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
[TBL] [Abstract][Full Text] [Related]
19. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
Huber SA; Lucas ZJ
J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
[No Abstract] [Full Text] [Related]
20. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
Fortner GW; Kuperman O; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
